Compared with CD133- GBC cells, CD133+ GBC cells demonstrated an increased potential for tumor formation, cell proliferation, invasion and resistance to chemotherapeutic agents 19-21, indicating that CD133+ cancer cell plays an important role in GBC tumorigenesis and progression. This evidence concerns the gene PROM1 and neoplasm.